• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者失明和下肢截肢未来风险预测方程的开发与验证:队列研究

Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.

作者信息

Hippisley-Cox Julia, Coupland Carol

机构信息

Division of Primary Care, Nottingham University, Nottingham NG2 7RD, UK

Division of Primary Care, Nottingham University, Nottingham NG2 7RD, UK.

出版信息

BMJ. 2015 Nov 11;351:h5441. doi: 10.1136/bmj.h5441.

DOI:10.1136/bmj.h5441
PMID:26560308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4641884/
Abstract

STUDY QUESTION

Is it possible to develop and externally validate risk prediction equations to estimate the 10 year risk of blindness and lower limb amputation in patients with diabetes aged 25-84 years?

METHODS

This was a prospective cohort study using routinely collected data from general practices in England contributing to the QResearch and Clinical Practice Research Datalink (CPRD) databases during the study period 1998-2014. The equations were developed using 763 QResearch practices (n=454,575 patients with diabetes) and validated in 254 different QResearch practices (n=142,419) and 357 CPRD practices (n=206,050). Cox proportional hazards models were used to derive separate risk equations for blindness and amputation in men and women that could be evaluated at 10 years. Measures of calibration and discrimination were calculated in the two validation cohorts.

STUDY ANSWER AND LIMITATIONS

Risk prediction equations to quantify absolute risk of blindness and amputation in men and women with diabetes have been developed and externally validated. In the QResearch derivation cohort, 4822 new cases of lower limb amputation and 8063 new cases of blindness occurred during follow-up. The risk equations were well calibrated in both validation cohorts. Discrimination was good in men in the external CPRD cohort for amputation (D statistic 1.69, Harrell's C statistic 0.77) and blindness (D statistic 1.40, Harrell's C statistic 0.73), with similar results in women and in the QResearch validation cohort. The algorithms are based on variables that patients are likely to know or that are routinely recorded in general practice computer systems. They can be used to identify patients at high risk for prevention or further assessment. Limitations include lack of formally adjudicated outcomes, information bias, and missing data.

WHAT THIS STUDY ADDS

Patients with type 1 or type 2 diabetes are at increased risk of blindness and amputation but generally do not have accurate assessments of the magnitude of their individual risks. The new algorithms calculate the absolute risk of developing these complications over a 10 year period in patients with diabetes, taking account of their individual risk factors.

FUNDING, COMPETING INTERESTS, DATA SHARING: JH-C is co-director of QResearch, a not for profit organisation which is a joint partnership between the University of Nottingham and Egton Medical Information Systems, and is also a paid director of ClinRisk Ltd. CC is a paid consultant statistician for ClinRisk Ltd.

摘要

研究问题

是否有可能开发并外部验证风险预测方程,以估计25至84岁糖尿病患者10年内失明和下肢截肢的风险?

方法

这是一项前瞻性队列研究,使用了在1998年至2014年研究期间从英格兰普通诊所常规收集的数据,这些数据被纳入QResearch和临床实践研究数据链(CPRD)数据库。该方程是利用763个QResearch诊所(454575例糖尿病患者)的数据开发的,并在254个不同的QResearch诊所(142419例患者)和357个CPRD诊所(206050例患者)中进行了验证。使用Cox比例风险模型分别推导男性和女性失明和截肢的风险方程,并在10年内进行评估。在两个验证队列中计算了校准和区分度的指标。

研究答案及局限性

已开发并外部验证了用于量化糖尿病男性和女性失明和截肢绝对风险的风险预测方程。在QResearch推导队列中,随访期间发生了4822例下肢截肢新病例和8063例失明新病例。风险方程在两个验证队列中校准良好。在外部CPRD队列中,男性截肢(D统计量1.69,Harrell's C统计量0.77)和失明(D统计量1.40,Harrell's C统计量0.73)的区分度良好,女性和QResearch验证队列的结果相似。这些算法基于患者可能知晓或在普通诊所计算机系统中常规记录的变量。它们可用于识别高危患者以进行预防或进一步评估。局限性包括缺乏正式判定的结果、信息偏倚和数据缺失。

本研究的新增内容

1型或2型糖尿病患者失明和截肢的风险增加,但通常对其个体风险的严重程度没有准确评估。新算法考虑了糖尿病患者的个体风险因素,计算了他们在10年内发生这些并发症的绝对风险。

资金、竞争利益、数据共享:JH - C是QResearch的联合主任,QResearch是一家非营利组织,是诺丁汉大学和埃格顿医学信息系统的联合合作伙伴,JH - C也是ClinRisk Ltd的付费董事。CC是ClinRisk Ltd的付费顾问统计学家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/47c805f318f3/coxj027121.f7_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/9553bd10f180/coxj027121.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/e04bf5b25ff1/coxj027121.f2_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/24c894c9b75e/coxj027121.f3_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/cbeb63ce03e4/coxj027121.f4_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/838f908219ed/coxj027121.f5_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/0a1af7214b04/coxj027121.f6_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/47c805f318f3/coxj027121.f7_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/9553bd10f180/coxj027121.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/e04bf5b25ff1/coxj027121.f2_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/24c894c9b75e/coxj027121.f3_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/cbeb63ce03e4/coxj027121.f4_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/838f908219ed/coxj027121.f5_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/0a1af7214b04/coxj027121.f6_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9608/4784861/47c805f318f3/coxj027121.f7_default.jpg

相似文献

1
Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.糖尿病患者失明和下肢截肢未来风险预测方程的开发与验证:队列研究
BMJ. 2015 Nov 11;351:h5441. doi: 10.1136/bmj.h5441.
2
Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.用于估计糖尿病患者未来心力衰竭风险的风险预测方程的开发与验证:一项前瞻性队列研究。
BMJ Open. 2015 Sep 9;5(9):e008503. doi: 10.1136/bmjopen-2015-008503.
3
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.用于估计2型糖尿病未来风险的QDiabetes-2018风险预测算法的开发与验证:队列研究
BMJ. 2017 Nov 20;359:j5019. doi: 10.1136/bmj.j5019.
4
Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.用于估计结直肠癌患者生存率的风险预测方程的开发与验证:队列研究
BMJ. 2017 Jun 15;357:j2497. doi: 10.1136/bmj.j2497.
5
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.用于估计心血管疾病未来风险的QRISK3风险预测算法的开发与验证:前瞻性队列研究
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
6
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.预测肺癌未来风险:CanPredict(肺部)模型在 1967 万人中的开发、内部和外部验证以及该模型与其他七个风险预测模型的性能评估。
Lancet Respir Med. 2023 Aug;11(8):685-697. doi: 10.1016/S2213-2600(23)00050-4. Epub 2023 Apr 5.
7
Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.男性和女性常见癌症未来风险预测算法的开发与验证:前瞻性队列研究
BMJ Open. 2015 Mar 17;5(3):e007825. doi: 10.1136/bmjopen-2015-007825.
8
Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.开发和验证风险预测算法(QThrombosis)以估计静脉血栓栓塞的未来风险:前瞻性队列研究。
BMJ. 2011 Aug 16;343:d4656. doi: 10.1136/bmj.d4656.
9
Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.用于估计短期死亡风险和评估虚弱程度的 Q 死亡率风险预测算法的开发与验证:队列研究
BMJ. 2017 Sep 20;358:j4208. doi: 10.1136/bmj.j4208.
10
The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.七种Q预测风险评分在来自全科医疗的独立外部患者样本中的表现:一项验证研究。
BMJ Open. 2014 Aug 28;4(8):e005809. doi: 10.1136/bmjopen-2014-005809.

引用本文的文献

1
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.自身免疫性疾病的自身免疫机制演变和新的治疗策略。
Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8.
2
Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.糖尿病大血管并发症与糖尿病微血管并发症风险增加相关:英国生物库中 1518 例 1 型糖尿病患者和 20802 例 2 型糖尿病患者的前瞻性研究。
J Am Heart Assoc. 2024 Jun 4;13(11):e032626. doi: 10.1161/JAHA.123.032626. Epub 2024 May 31.
3

本文引用的文献

1
Intensive diabetes therapy and ocular surgery in type 1 diabetes.1型糖尿病的强化糖尿病治疗与眼科手术
N Engl J Med. 2015 Apr 30;372(18):1722-33. doi: 10.1056/NEJMoa1409463.
2
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.透明报告个体预后或诊断的多变量预测模型(TRIPOD):TRIPOD 声明。
Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697.
3
Validation of the IMS CORE Diabetes Model.IMS核心糖尿病模型的验证
Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment.
全身因素在改善糖尿病视网膜病变预后及预测糖尿病视网膜病变治疗反应中的作用
Ophthalmol Sci. 2024 Feb 17;4(4):100494. doi: 10.1016/j.xops.2024.100494. eCollection 2024 Jul-Aug.
4
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases.汇总初级保健电子健康记录 (EHR) 中亨廷顿病 (HD) 和癌症的数据:建立两个大型英国数据库的可比性。
BMJ Open. 2024 Feb 14;14(2):e070258. doi: 10.1136/bmjopen-2022-070258.
5
Evaluation and Optimization of Diabetic Retinopathy Screenings for Uninsured Latinx Patients in a Resource-Limited Student-Run Free Clinic.资源有限的学生运营免费诊所中未参保拉丁裔患者糖尿病视网膜病变筛查的评估与优化
J Stud Run Clin. 2024 Jan 18;10(1). doi: 10.59586/jsrc.v10i1.407.
6
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.接受冠状动脉介入治疗后接受双联抗血小板治疗和三联治疗的患者的出血风险:ADAPTT 回顾性基于人群的队列研究。
Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014.
7
Interpretable machine learning-derived nomogram model for early detection of diabetic retinopathy in type 2 diabetes mellitus: a widely targeted metabolomics study.基于可解释机器学习的 2 型糖尿病糖尿病视网膜病变早期检测列线图模型:一项广泛靶向代谢组学研究。
Nutr Diabetes. 2022 Aug 5;12(1):36. doi: 10.1038/s41387-022-00216-0.
8
Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings.2型糖尿病患者视力威胁性糖尿病视网膜病变预测风险模型的开发与验证,以用作资源有限环境中的分诊工具。
EClinicalMedicine. 2022 Jul 22;51:101578. doi: 10.1016/j.eclinm.2022.101578. eCollection 2022 Sep.
9
Precision prognostics for the development of complications in diabetes.糖尿病并发症发展的精准预测。
Diabetologia. 2022 Nov;65(11):1867-1882. doi: 10.1007/s00125-022-05731-4. Epub 2022 Jun 21.
10
T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications.T1DMicro:1型糖尿病相关微血管并发症的临床风险计算器
Int J Environ Res Public Health. 2021 Oct 21;18(21):11094. doi: 10.3390/ijerph182111094.
Value Health. 2014 Sep;17(6):714-24. doi: 10.1016/j.jval.2014.07.007.
4
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
5
HbA1c and lower-extremity amputation risk in low-income patients with diabetes.低收入糖尿病患者的糖化血红蛋白与下肢截肢风险
Diabetes Care. 2013 Nov;36(11):3591-8. doi: 10.2337/dc13-0437. Epub 2013 Sep 23.
6
Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.基于初级保健的 QStroke 评分预测缺血性卒中风险的推导和验证,并与其他风险评分比较:一项前瞻性开放队列研究。
BMJ. 2013 May 2;346:f2573. doi: 10.1136/bmj.f2573.
7
Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.在英国预测心血管疾病 10 年风险:QRISK2 新版本的独立和外部验证。
BMJ. 2012 Jun 21;344:e4181. doi: 10.1136/bmj.e4181.
8
External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.QDSCORE(®) 预测 10 年发生 2 型糖尿病风险的外部验证。
Diabet Med. 2011 May;28(5):599-607. doi: 10.1111/j.1464-5491.2011.03237.x.
9
Multiple imputation using chained equations: Issues and guidance for practice.使用链式方程进行多重插补:实践中的问题和指导。
Stat Med. 2011 Feb 20;30(4):377-99. doi: 10.1002/sim.4067. Epub 2010 Nov 30.
10
Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.预测英格兰和威尔士男性和女性慢性肾脏病的风险:QKidney 评分的前瞻性推导和外部验证。
BMC Fam Pract. 2010 Jun 21;11:49. doi: 10.1186/1471-2296-11-49.